The Profound Impact of Socioeconomic Status in the Body

While cutting-edge treatments like CAR-T cell therapy and monoclonal antibodies are revolutionizing cancer care, stem cell transplants remain a lifeline for a subset of patients battling blood cancers. A groundbreaking new study reveals a surprising factor that could influence the success of these transplants: the socioeconomic status of the stem cell donor.

Uncovering a Hidden Link

Researchers from the University of Minnesota embarked on a large-scale study to investigate this potential connection. Examining data from 2,005 patients (most of them had a diagnosis of acute myeloid leukemia) who underwent allogeneic stem cell transplants for blood cancers at 125 hospitals across the United States. They sought to determine if there was any association between a donor's neighborhood's socioeconomic status (SES) and the long-term health of the recipient.

Striking Disparities in Outcomes

The results of the study were eye-opening. Published in the Proceedings of the National Science Academy, the study revealed that patients who received stem cells from donors living in low-income areas experienced a 6.6% higher transplant-related mortality rate and a 9.7% reduction in overall survival over three years compared to those whose donors resided in wealthier areas. This disparity persisted even after accounting for other factors known to influence transplant outcomes, such as race and health insurance status.

A Legacy in the Cells?

This discovery adds a new dimension to our understanding of how socioeconomic disadvantage can impact health. Previous research has linked poverty to poorer diets, increased exposure to pollutants, and chronic stress – all factors contributing to inflammation and negatively impacting the immune system function and hematopoiesis (the formation of blood cellular components). However, the groundbreaking aspect of this study is the suggestion that these effects might persist even after the cells are transferred to a new host environment.

“The importance of these findings reaches far beyond cancer and bone marrow transplant care; they demonstrate the profound health effects of social inequality and highlight the critical need for public health interventions” Lucie Turcotte, MD, MPH, MS, University of Minnesota Masonic Children’s Hospital Pediatric Specialty Care Journey Clinic.

Working Towards a More Equitable Future

This latest study takes our understanding of poverty's influence to another level, suggesting that socioeconomic disadvantage might have a lasting impact on cells at a biological level, an impact that endures even when those cells are transplanted into another person's body.

"This study suggests that there is a biological effect of poverty," said Dr. Jeff Auletta, a senior vice president of health equity for the National Marrow Donor Program.

The findings underscore the need for a multifaceted approach to improving health equity in stem cell transplantation. The research team is now focusing on understanding the underlying biological and physiological mechanisms driving these findings. Their ultimate goal is to develop interventions that can mitigate the adverse health outcomes associated with donor socioeconomic disadvantage, ensuring that all stem cell recipients have the best possible chance at a healthy future.

The HealthTree Coach program offers free 1:1 help from a financial coach. If you or a loved one need help navigating the financial challenges of cancer diagnosis and treatment, email Diahanna Vallentine to receive help. 

Sources: 

• The health risk of social disadvantage is transplantable into a new host
• New study finds cell donor’s socioeconomic status shapes cancer treatment outcomes
• University of Minnesota documents stunning impact of poverty on cell function, transplants
• Donor Socioeconomic Status May Influence Outcomes in Hematopoietic Cell Transplantation